Role of Mitochondria and ROS in Health and Disease—2nd Edition

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "ROS, RNS and RSS".

Deadline for manuscript submissions: 20 November 2026 | Viewed by 3855

Special Issue Editors


E-Mail Website
Guest Editor
Department of Biology, University Federico II of Naples, Via Cinthia 26, 80126 Naples, Italy
Interests: reactive oxygen species; vitamin e; insulin resistance; mitochondria; ROS; oxidative stress; antioxidants; hypoxia; microplastics; nanoplastics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Mitochondria perform a multitude of essential functions within eukaryotic cells and engage in extensive communication with virtually all other cellular organelles. Their primary role is to generate cellular energy through the process of oxidative phosphorylation. This process is intrinsically linked to the production of reactive oxygen species (ROS), molecules that have a hormetic behaviour. While excessive ROS can damage cellular components, including the mitochondria themselves, at controlled levels they serve as important regulators of cellular function.

Mitochondria possess an efficient and adaptable antioxidant defence system able to not only neutralise mitochondrial-derived ROS but also contribute to the detoxification of ROS from other intracellular sources, positioning mitochondria as key regulators of cellular redox homeostasis.

Controlled ROS production plays a critical role in cell signalling, acting as secondary messengers in a range of physiological processes, including adaptation to hypoxia, autophagy regulation, immune response modulation, cellular differentiation, longevity, and metabolic adaptation to physical activity.

Under pathological or stress-related conditions, ROS production can become excessive. This disrupts mitochondrial integrity and initiates a deleterious cycle wherein oxidative damage to components of the respiratory chain, and the Krebs cycle leads to further ROS overproduction. This positive feedback loop amplifies oxidative stress, resulting in widespread cellular injury and functional decline. The progressive accumulation of oxidative damage and loss of mitochondrial integrity are central to the development of numerous non-communicable diseases. These insights underscore the urgent need for a deeper understanding of ROS-related signalling pathways and the identification of strategic molecular targets for effective therapeutic intervention.

We invite you to submit to this second edition of the Special Issue your latest research or a review article aimed at elucidating the fundamental role of mitochondria in modulating cellular ROS dynamics. In addition, the Special Issue’s scope has been broadened to encompass the identification and characterisation of natural bioactive compounds derived from plant and animal-based food matrices that exhibit the capacity of modulating mitochondrial function.

Dr. Paola Venditti
Dr. Gaetana Napolitano
Dr. Gianluca Fasciolo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • ROS
  • mitochondria
  • antioxidants
  • oxidative stress
  • neurological diseases
  • metabolic diseases
  • retinal diseases
  • mitochondrial disfunctions
  • mitochondria endoplasmic reticulum communication
  • mitochondrial bioenergetics
  • ageing
  • physical activity

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

26 pages, 6929 KB  
Article
A Standardized Onion Peel-Derived Bioactive Ingredient Attenuates Palmitate-Induced Steatosis and Oxidative Stress by Modulating Mitochondrial Dynamics and Autophagy in HepG2 Cells
by Ilaria Di Gregorio, Vincenzo Migliaccio, Maria D’Elia, Rita Celano, Valentina Santoro, Anna Lisa Piccinelli, Mariateresa Russo, Luca Rastrelli and Lillà Lionetti
Antioxidants 2026, 15(4), 513; https://doi.org/10.3390/antiox15040513 - 21 Apr 2026
Viewed by 569
Abstract
Onion peel represents a valuable food by-product rich in bioactive phenolic compounds. Building on previous phytochemical investigations, an onion peel extract from the Rossadi Tropea variety was developed as a standardized bioactive ingredient (OPI-T), defined by flavonol (quercetin and its glycosylated and [...] Read more.
Onion peel represents a valuable food by-product rich in bioactive phenolic compounds. Building on previous phytochemical investigations, an onion peel extract from the Rossadi Tropea variety was developed as a standardized bioactive ingredient (OPI-T), defined by flavonol (quercetin and its glycosylated and oxidized derivatives) and anthocyanin (cyanidin derivatives) markers, ensuring batch-to-batch consistency, and evaluated for its potential against hepatic steatosis. The present study aimed to assess the protective effects of OPI-T against palmitate-induced steatosis and oxidative stress in HepG2 cells, a widely used in vitro model of hepatic lipid accumulation. An onion peel extract derived from the Ramata di Montoro variety was included as a natural negative reference to account for varietal variability. HepG2 cells were co-treated with palmitate (500 µM) and OPI-T (25 or 50 µg/mL). Lipid accumulation was evaluated by Oil Red O and BODIPY staining, while oxidative stress was assessed by the DCF assay. Mitochondrial dynamics and autophagy were investigated through the analysis of key protein markers, including MFN2, DRP1, SQSTM1/p62 and LC3 II/I. OPI-T significantly attenuated palmitate-induced lipid accumulation (−18%) and reduced intracellular ROS production (−75%), while modulating mitochondrial dynamics toward a reduced fission phenotype with a marked increase in the MFN2/DRP1 ratio (1.66) and improving autophagy flux. In contrast, the Ramata di Montoro variety showed weaker or inconsistent effects under the same experimental conditions. Overall, these findings support the functional validation of a standardized onion peel-derived ingredient, highlighting its potential application as a bioactive component for functional food or nutraceutical development targeting hepatic steatosis and oxidative stress. Full article
(This article belongs to the Special Issue Role of Mitochondria and ROS in Health and Disease—2nd Edition)
Show Figures

Graphical abstract

22 pages, 8944 KB  
Article
M2 Macrophage-Derived Exosomes Ameliorate BPD by Inhibiting Ferroptosis via Suppression of the ZAKα-p38 Signaling Pathway
by Yuhan Pu, Mingyue Lv, Ru Yan, Honglian Zhang, Lihui Yu, Weilai Jin, Le Zhang, Zhiwei Yu and Yahui Zhou
Antioxidants 2026, 15(3), 326; https://doi.org/10.3390/antiox15030326 - 5 Mar 2026
Viewed by 800
Abstract
Background: Bronchopulmonary dysplasia (BPD) is a common lung disease in premature infants. Hyperoxia-induced oxidative stress and ferroptosis are key pathological mechanisms leading to alveolar epithelial (AT) cell injury and impaired alveolar development. M2 macrophage-derived exosomes (M2-Exo), as intercellular communication carriers, have potential protective [...] Read more.
Background: Bronchopulmonary dysplasia (BPD) is a common lung disease in premature infants. Hyperoxia-induced oxidative stress and ferroptosis are key pathological mechanisms leading to alveolar epithelial (AT) cell injury and impaired alveolar development. M2 macrophage-derived exosomes (M2-Exo), as intercellular communication carriers, have potential protective effects in regulating oxidative stress-related diseases, but the molecular mechanism by which they exert effects by regulating ferroptosis in BPD remains unclear. Objective: To explore the protective effect of M2-Exo on hyperoxia or inflammation-induced BPD models and clarify its antioxidant mechanism. Method: In vitro AT cell injury models and in vivo BPD models were constructed by hyperoxia or LPS induction. M2-Exo were isolated, identified, and used to intervene in models. Oxidative stress and ferroptosis-related indicators (ROS, MDA, iron accumulation, GPX4), AT cell functional markers (AQP5, SPC), and ZAKα-p38 pathway activation contents were detected. ZAKα overexpression was used to verify pathway dependence. Results: M2-Exo intervention significantly enhanced AT cell viability, upregulated the expression of AQP5 and SPC, and reversed alveolar simplification. Concurrently, it effectively suppressed hyperoxia or LPS-induced oxidative stress and ferroptosis, as evidenced by reduced contents of ROS and MDA, diminished iron accumulation, and GPX4 expression. Mechanistically, M2-Exo significantly inhibited the activation of the ZAKα-p38 pathway, and ZAKα overexpression could antagonize the antioxidant, anti-ferroptotic, and AT cell protective effects of M2-Exo. Conclusions: M2-Exo alleviate AT cell oxidative stress and ferroptosis by inhibiting the ZAKα-p38 pathway, thereby improving hyperoxia or inflammation-induced BPD and providing a new strategy and molecular target for the antioxidant treatment of BPD. Full article
(This article belongs to the Special Issue Role of Mitochondria and ROS in Health and Disease—2nd Edition)
Show Figures

Figure 1

22 pages, 3109 KB  
Article
Chlorogenic Acid Alleviates the Detrimental Effects of Concurrent Hyperglycemia and Chronic Stress on Brain Homeostasis by Modulating Antioxidative Defense in Adult Zebrafish
by Rhea Subba, Gianluca Fasciolo, Adriana Petito, Eugenio Geremia, Maria Teresa Muscari Tomajoli, Amal Chandra Mondal, Gaetana Napolitano and Paola Venditti
Antioxidants 2025, 14(12), 1386; https://doi.org/10.3390/antiox14121386 - 21 Nov 2025
Cited by 1 | Viewed by 1412
Abstract
Oxidative stress is a key contributor to diabetes-related cognitive decline and is intensified by diabetes distress (DD), the psychological burden of disease management. DD lowers brain levels of nuclear factor erythroid 2-related factor 2 (NRF2), a transcription factor that regulates antioxidant defense. This [...] Read more.
Oxidative stress is a key contributor to diabetes-related cognitive decline and is intensified by diabetes distress (DD), the psychological burden of disease management. DD lowers brain levels of nuclear factor erythroid 2-related factor 2 (NRF2), a transcription factor that regulates antioxidant defense. This study examined whether chlorogenic acid (CGA), a polyphenolic NRF2 activator, could counteract oxidative and astroglial dysfunctions in adult zebrafish subjected to chronic unpredictable mild stress (CUMS) combined with dextrose, a model mimicking DD. Zebrafish were treated with CGA (50, 100, or 200 mg/kg), and the levels of NRF2 protein and mRNA, along with its regulator keap1, were quantified. Expression levels of key downstream antioxidant genes (sod1, sod2, catalase, glutathione peroxidase, and glutamate-cysteine ligase catalytic subunit) were assessed alongside glutathione (GSH) content and superoxide dismutase (SOD) and catalase activities. Astroglial integrity was evaluated via glial fibrillary acidic protein (GFAP) levels in the whole brain and stress-sensitive regions. CGA increased total brain NRF2 protein, its mRNA, and those of its downstream effectors. At 200 mg/kg, CGA restored GSH levels, boosted antioxidant enzyme activities, and mitigated DD-associated reductions in GFAP and NRF2 in stress-vulnerable areas. These findings identify NRF2 as a promising target to protect brain health under diabetic conditions. Full article
(This article belongs to the Special Issue Role of Mitochondria and ROS in Health and Disease—2nd Edition)
Show Figures

Figure 1

Back to TopTop